Sanofi (SAN.FP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 5,946,475 | 2,516,226 | 389,075 | 379,282 | 301,000 |
| Income taxes - deferred | -2,098,110 | N/A | -15,087 | 63,849 | 75,000 |
| Accounts receivable | -737,083 | 8,852 | -205,654 | -18,106 | -235,000 |
| Other Working Capital | -238,940 | 111,390 | -162,776 | -595,606 | -270,000 |
| Other Operating Activity | 3,520,773 | 1,389,789 | 2,255,839 | 1,847,809 | 1,947,000 |
| Operating Cash Flow | $6,393,115 | $4,026,257 | $2,261,397 | $1,677,227 | $1,818,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -409,490 | 964,148 | -343,021 | -1,382,759 | 492,000 |
| Net Acquisitions | -695,711 | -15,084,081 | -10,322 | N/A | N/A |
| Purchase Of Investment | N/A | N/A | N/A | -32,401 | N/A |
| Other Investing Activity | 5,066 | -11,803 | 3,970 | 4,765 | -605,000 |
| Investing Cash Flow | $-1,100,136 | $-14,131,736 | $-349,373 | $-1,410,396 | $-113,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | -1,000 |
| Debt Issued | N/A | N/A | N/A | N/A | 9,000 |
| Debt Repayment | N/A | N/A | N/A | N/A | -12,000 |
| Common Stock Issued | 418,778 | 8,852 | 7,146 | 3,812 | 7,000 |
| Common Stock Repurchased | N/A | N/A | -1,001,272 | -1,171,200 | N/A |
| Dividend Paid | -1,612,632 | -734,729 | -581,230 | -476,485 | -323,000 |
| Other Financing Activity | -4,786,393 | 9,940,976 | -19,851 | 51,460 | -163,000 |
| Financing Cash Flow | $-5,980,248 | $9,215,099 | $-1,595,206 | $-1,592,413 | $-483,000 |
| Exchange Rate Effect | 97,096 | -22,868 | -16,675 | -16,200 | 3,000 |
| Beginning Cash Position | 1,838,907 | 2,762,612 | 2,460,699 | 3,808,068 | 2,580,000 |
| End Cash Position | 1,247,890 | 1,849,364 | 2,760,048 | 2,467,239 | 3,805,000 |
| Net Cash Flow | $-687,268 | $-890,380 | $316,818 | $-1,325,581 | $1,222,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 6,393,115 | 4,026,257 | 2,261,397 | 1,677,227 | 1,818,000 |
| Capital Expenditure | -1,142,351 | N/A | -370,018 | -1,404,678 | -565,000 |
| Free Cash Flow | 5,250,764 | 4,026,257 | 1,891,379 | 272,549 | 1,253,000 |